Continuous lipase-catalyzed production of pseudo-ceramides in a packed-bed bioreactor

• Published in: Journal of Molecular Catalysis B: Enzymatic
• Main Authors: Le Joubioux, Florian, Bridiau, Nicolas, Sanekli, Mehdi, Graber, Marianne, Maugard, Thierry
• Other Authors: LIttoral ENvironnement et Sociétés - UMRi 7266 (LIENSs), Université de La Rochelle (ULR)-Centre National de la Recherche Scientifique (CNRS), ANR Expenantio, ANR-08-CP2D-0010,EXPENANTIO,Vers une voie durable pour la synthèse de molécules chirales: approches expérimentales et théoriques innovantes pour la compréhension des bases moléculaires de l'énantiosélectivité des lipases et des estérases - Towards green synthesis of chiral molecules(2008)
• Format: Article in Journal/Newspaper
• Language: English
• Published: HAL CCSD 2014
• Subjects: [SDV.BIO]Life Sciences [q-bio]/Biotechnology; [INFO.INFO-BT]Computer Science [cs]/Biotechnology; Antarc*; Antarctica
• Online Access: https://hal.archives-ouvertes.fr/hal-01070430; https://hal.archives-ouvertes.fr/hal-01070430/document; https://hal.archives-ouvertes.fr/hal-01070430/file/Article_HAL.pdf; https://doi.org/10.1016/j.molcatb.2014.08.022

International audience Ceramides are spingolipid compounds that are very attractive as active components in both the phar-maceutical and the cosmetic industries. In this study, the synthesis of ceramide analogs, the so-calledpseudo-ceramides, was carried out using for the first time a two-step continuous enzymatic processwith immobilized Candida antarctica lipase B (Novozym®435) in a packed-bed bioreactor. The first stepinvolved the selective N-acylation of 3-amino-1,2-propanediol using stearic acid as the first acyl donor(i). This was followed by the selective O-acylation of the N-stearyl 3-amino-1,2-propanediol synthesizedin the first step, with myristic acid as the second acyl donor, to produce a N,O-diacyl 3-amino-1,2-propanediol-type pseudo-ceramide, namely 1-O-myristyl,3-N-stearyl 3-amino-1,2-propanediol (ii). Theprocess was first optimized by evaluating the influences of three factors: feed flow rate, quantity of bio-catalyst and substrate concentration. Under optimal conditions an amide synthesis yield of 92% and asatisfying production rate of almost 3.15 mmol h−1gbiocatalyst−1(1128 mg h−1gbiocatalyst−1) were obtained.The second step, N-acyl 3-amino-1,2-propanediol O-acylation, was similarly optimized and in additionthe effect of the substrate molar ratio was studied. Thus, an optimal pseudo-ceramide synthesis yield of54% and a production rate of 0.46 mmol h−1gbiocatalyst−1(261 mg h−1gbiocatalyst−1) were reached at a 1:3ratio of amide to fatty acid. In addition, it was demonstrated that this two-step process has great potentialfor the production of N,O-diacyl 3-amino-1,2-propanediol-type pseudo-ceramides on an industrial scale.It was shown in particular that Novozym®435 could be used for more than 3 weeks without a drop inthe yield during the first step of 3-amino-1,2-propanediol N-acylation, proving that this biocatalyst isvery stable under these operational conditions. This factor would greatly reduce the need for biocatalystreplacement and significantly lower the associated cost.